
|Articles|December 4, 2004
Cymbalta receives FDA OK for depression maintenance
Duloxetine approved for maintenance of MDD
Advertisement
Eli Lilly & Co. has received regulatory word that antidepressant duloxetine (
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Expands Approval of Flibanserin for Postmenopausal Women’s Sexual Health
2
Why Trump’s Second Term is Different for the MFN Drug Pricing Policy
3
Pharmacists Can Play Central Role in Patients’ Infusion Services | ASHP Midyear 2025
4
Taking Care of Every Patient in Every Pharmacy
5




























































































































